МЫ ПОЛНОСТЬЮ ВОЗОБНОВИЛИ ПРИЕМ ПАЦИЕНТОВ ДО 18 ЛЕТ НА ПРОГРАММЫ КЛЕТОЧНОЙ ТЕРАПИИ СТВОЛОВЫМИ КЛЕТКАМИ САХАРНОГО ДИАБЕТА 1 типа

МЫ ПОЛНОСТЬЮ ВОЗОБНОВИЛИ ПРИЕМ ПАЦИЕНТОВ ДО 18 ЛЕТ НА ПРОГРАММЫ КЛЕТОЧНОЙ ТЕРАПИИ СТВОЛОВЫМИ КЛЕТКАМИ САХАРНОГО ДИАБЕТА 1 типа

После снятия ограничений по Ковид-19, мы полностью восстановили программы клеточной терапии (комбинированной терапии, иммунотерапии) для детей и подростков с диагнозом сахарный диабет 1 типа.

Dr.Kampon  is an internationally recognized pioneer of Celltherapy who received M.D. degree and Ph.D. degree from Mahidol University where he had an academic career for more than 35 years.
He also received training in Clinical Pharmacology from University of Leicester, U.K. and University of Rochester, N.Y., USA.

His present academic position is Advisor of Alternative Medicine, Mae Fah Luang University Hospital. He is a member of Thailand’s Medical Association, the Pharmacological and Therapeutic Society and the Toxicological Society. He was the Founder of the Thai Society of Cellular Therapy (TSCT) and is now its Executive Secretary. He is also member of the International Society for Cellular Therapy (ISCT).

Spearheaded a number of important research and development activities related to Stem Cell Technology in Thailand, including setting up of Cord Blood and Tooth cell banking.

Has received several awards for research and innovation from British and American academic institutions and the National Innovation Agency of Thailand.